OS Fund — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Arzedaarzeda.com in 𝕏Series A · Jul 2017 · $15M

Arzeda designs proteins and metabolic pathways using computational tools, including its Archytas protein design software and Scylax metabolic pathway design software.

AI & Machine LearningBiotechDeep TechFoodTechNew MaterialsSeattle, US

Alexandre Zanghellini(Co-Founder & Chief Executive Officer)in Eric Althoff(Executive Officer, Director, Promoter)inDavid Baker(Co-founder and Scientific Advisor)Bill Baum(Director)inAndrew Ban(Executive Officer)Daniela Grabs(Executive Officer)

Co-investorsCirculate Capital Fall Line Capital Sofinnova Partners Sustainable Conversion Ventures Continental Grain Company Lewis & Clark AgriFood +2 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.